[go: up one dir, main page]

MX9504023A - Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion. - Google Patents

Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.

Info

Publication number
MX9504023A
MX9504023A MX9504023A MX9504023A MX9504023A MX 9504023 A MX9504023 A MX 9504023A MX 9504023 A MX9504023 A MX 9504023A MX 9504023 A MX9504023 A MX 9504023A MX 9504023 A MX9504023 A MX 9504023A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
composition containing
active pharmaceutical
aminolaevulinic acid
transdermally active
Prior art date
Application number
MX9504023A
Other languages
English (en)
Inventor
Jue-Chen Liu
Mohammed Yusuf
Catherine Huddleston
Jonas C T Wang
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MX9504023A publication Critical patent/MX9504023A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invencion se refiere a una composicion estable al almacenamiento, fácil de usar, para usarse en el tratamiento de cáncer, que contiene ácido 5-aminolaevulínico o sus derivados y tiene un pH de alrededor de 1.8 a aproximadamente 4.5.
MX9504023A 1994-09-20 1995-09-20 Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion. MX9504023A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30929694A 1994-09-20 1994-09-20

Publications (1)

Publication Number Publication Date
MX9504023A true MX9504023A (es) 1997-05-31

Family

ID=23197596

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9504023A MX9504023A (es) 1994-09-20 1995-09-20 Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.

Country Status (6)

Country Link
EP (1) EP0704209A1 (es)
JP (1) JPH08175986A (es)
AU (1) AU3176695A (es)
BR (1) BR9504090A (es)
CA (1) CA2158724A1 (es)
MX (1) MX9504023A (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19744811C2 (de) * 1997-10-02 1999-11-18 Medac Klinische Spezialpraep Verwendung von delta-Aminolävulinsäure zur Herstellung eines topischen Arzneimittels zur integralen Diagnose und/oder Therapie von Tumoren in Hohlorganen
DE19744621A1 (de) * 1997-10-09 1999-04-15 Muehlbauer Ernst Kg Mischung zur Verwendung als Wundverband
DE19852245A1 (de) 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
DE10034673C1 (de) * 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
KR20030024329A (ko) * 2001-09-18 2003-03-26 (주)엔바이로젠 델타-아미노레불린산을 함유하는 피부재생촉진용 세정제및 화장료 조성물
DE10202487A1 (de) 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate
US20040009212A1 (en) * 2002-01-30 2004-01-15 Pharma Power Biotec Co. Ltd. Mucoadhesive thermoresponsive medicament-carrier composition
JP2006151927A (ja) * 2004-12-01 2006-06-15 Toin Gakuen 光線力学的治療用組成物
EP1938801A1 (en) 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
JP5098051B2 (ja) 2007-04-05 2012-12-12 Ｓｂｉファーマ株式会社 ミトコンドリア障害脳疾患治療剤及び診断剤
JP5081121B2 (ja) * 2008-10-17 2012-11-21 株式会社ミルボン 育毛剤組成物
EP2440199B1 (en) * 2009-06-11 2016-04-13 Photocure ASA Semi-solid compositions and pharmaceutical products
PL229756B1 (pl) * 2014-11-12 2018-08-31 Tarchominskie Zaklady Farmaceutyczne Polfa Spólka Akcyjna Krem do stosowania w diagnostyce i terapii z zastosowaniem metody fotodynamicznej
JPWO2018043240A1 (ja) * 2016-09-02 2019-06-24 Ｓｂｉファーマ株式会社 ５−アミノレブリン酸類を含む水性製剤
WO2024208433A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Nanoemulsion without propylene glycol
WO2024208434A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Pressurized nanoemulsion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300526A (en) * 1984-07-27 1994-04-05 The Board Of Trustees Of The University Of Illinois Porphyric insecticides
US5079262A (en) * 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid

Also Published As

Publication number Publication date
BR9504090A (pt) 1996-09-24
EP0704209A1 (en) 1996-04-03
CA2158724A1 (en) 1996-03-21
AU3176695A (en) 1996-04-04
JPH08175986A (ja) 1996-07-09

Similar Documents

Publication Publication Date Title
MX9504023A (es) Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
SI0725779T1 (es)
IL107109A0 (en) Compounds for modifying drug resistance and pharmaceutical compositions containing the same
FI972086A7 (fi) Parannetun monilääkeresistenssiaktiivisuuden omaavat uudet aminohappoj ohdokset
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
NZ237023A (en) 17beta-substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions
ZA943744B (en) Therapeutic substituted guanidines
PL329802A1 (en) Derivatives of androstene
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
CA2108903A1 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
WO1998009599A3 (en) The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
NZ319138A (en) Composition containing cytochrome complex III and fenazaquin for combatting parasitic fungi
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
BG103632A (en) Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
GB1474424A (en) Pharmaceutical composition for treating diabetic ketoacidosis
GEP20043286B (en) Dual Inhibitors of Cholesteryl Ester and Wax Ester Synthesis for Sebaceous Gland Disorders
RU94040865A (ru) Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
TW218011B (es)
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation